Bellevue Group’s LB Pharmaceuticals LBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding LBRX
Bellevue Group's LBRX Position: Q3 2026 in Review
Bellevue Group opened a new position in LB Pharmaceuticals (LBRX) in Q3 2026: 715,513 shares worth $27.5M. The stake represents 0.57% of the portfolio and ranks #43 among its holdings.
147 funds tracked by Wall St. Rank hold LBRX as of Q3 2026.
- Bellevue Group held 715,513 shares of LB Pharmaceuticals worth $27.5M as of Q3 2026.
- LB Pharmaceuticals was a new Bellevue Group position in Q3 2026.
- LB Pharmaceuticals made up 0.57% of Bellevue Group's portfolio in Q3 2026, its #43 holding.
- 147 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q3 2026.
Based on Bellevue Group's 13F filing for Q3 2026, filed 16 Nov 2026.